Allergan’s Ubrelvy bags US approval for migraine
admin 24th December 2019 Uncategorised 0The drug is the first oral CGRP receptor antagonist approved to treat acute migraines
More: Allergan’s Ubrelvy bags US approval for migraine
Source: News
The drug is the first oral CGRP receptor antagonist approved to treat acute migraines
More: Allergan’s Ubrelvy bags US approval for migraine
Source: News
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' drug pricing rule
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' d
Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots
Feds consider half-doses of Moderna COVID-19 vaccine to stretch suppl
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 wit
© 1994 - 2021 B.M. Pharmaceuticals